FDA Extends Review Period for Applied Therapeutics’ Govorestat by Three Months
FDA Extends Review Period for Applied Therapeutics’ Govorestat by Three Months 3/29/2024
FDA Extends Review Period for Applied Therapeutics’ Govorestat by Three Months 3/29/2024